ReviewJournal of neurotrauma2017

Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.

Randy B Howard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.